1. Home
  2. PASG vs FCUV Comparison

PASG vs FCUV Comparison

Compare PASG & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PASG

Passage Bio Inc.

HOLD

Current Price

$11.03

Market Cap

28.6M

Sector

Health Care

ML Signal

HOLD

Logo Focus Universal Inc.

FCUV

Focus Universal Inc.

HOLD

Current Price

$1.10

Market Cap

25.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PASG
FCUV
Founded
2017
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
25.3M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
PASG
FCUV
Price
$11.03
$1.10
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$34.50
N/A
AVG Volume (30 Days)
48.9K
35.6K
Earning Date
11-10-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$387,457.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.12
$1.34
52 Week High
$20.20
$10.90

Technical Indicators

Market Signals
Indicator
PASG
FCUV
Relative Strength Index (RSI) 62.96 19.19
Support Level $8.64 $3.41
Resistance Level $11.32 $3.67
Average True Range (ATR) 0.92 0.34
MACD 0.05 -0.25
Stochastic Oscillator 78.92 1.03

Price Performance

Historical Comparison
PASG
FCUV

About PASG Passage Bio Inc.

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.

About FCUV Focus Universal Inc.

Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.

Share on Social Networks: